Insilicom provides advanced next-generation sequencing data analysis solutions for cancer research biomarker discovery.
Insilicom provides advanced next-generation sequencing data analysis solutions for cancer research biomarker discovery. The company was founded in 2013 and is headquartered in Tallahassee, Florida.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 3, 2014 | Grant | $225K | 1 |
National Science Foundation
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Science Foundation
|
Yes | Grant |